This is going to continue to be up in the air, as I believe GSK will have a rebuttal of some sort, or maybe none at all until their new are drugs are refined and tested on humans.
Lets see how this is playing out:
First, we know that Pfizer is ranked the number 1 Pharma in the world, GSK is ranked as the number 2 Pharma in the world...
As a friend has recently told me, this really appears to be more of a setup for Pfizer's marketing team, as Pfizer is working on their own 'drugs' that deal with the same issues that Resveratrol is supposed to deal with. Remember, the FDA does not consider longevity or aging as a something to be cured so the battle will be about the benefits regarding diseases that the FDA recognizes.
Personally I believe this is aimed at market share in a continuous battle between the behomths of the pharma industry.
Then again, if I were cynical... I would say that this may start a misinformation campaign about res. Which will be good for both pharmas in the industry, as it will have folks walk away from a natural solution to pay for the more expensive 'drugs' that are only available through one of the big Pharmas...
So to sum up where my train of thought is headed: I don't think GSK really cares about this study from Pfizer, as it could only benefit them in the eyes of consumers who will believe studies paid for and generated by big pharmas, over the other unbiased university studies which seem to provide a lot of evidence for the possible benefits of resveratrol regardless of SIRT1 activation ...
Strange bedfellows, these 2 big pharmas? Maybe.
But, alas... I am no cynic, (well at least not most of the time).
Cheers
A
Edited by Anthony_Loera, 29 January 2010 - 10:03 PM.